Sunshine Biopharma (SBFM)
1.1700 x 13 1.3000 x 18
Post-market by (Cboe BZX)
1.2500 +0.0300 (+2.46%) 04/17/25 [NASDAQ]
1.1700 x 13 1.3000 x 18
Post-market 1.2014 -0.0486 (-3.89%) 16:14 ET
for Thu, Apr 17th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,134 | -4,506 | -26,744 | -12,437 | -2,784 |
| Depreciation Amortization | 224 | 149 | 18,352 | 13 | 14 |
| Income taxes - deferred | N/A | N/A | 4 | N/A | N/A |
| Accounts receivable | -2,338 | -594 | -525 | -6 | -2 |
| Other Working Capital | -7,633 | -4,418 | 3,151 | -109 | -43 |
| Other Operating Activity | 2,350 | 594 | 514 | 10,709 | 2,157 |
| Operating Cash Flow | $-12,531 | $-8,775 | $-5,248 | $-1,829 | $-657 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,657 | -82 | -194 | N/A | -1 |
| Net Acquisitions | N/A | N/A | -14,348 | N/A | N/A |
| Purchase Sale Intangibles | -322 | -706 | -111 | N/A | N/A |
| Other Investing Activity | -664 | -574 | -78 | 0 | 0 |
| Investing Cash Flow | $-2,321 | $-656 | $-14,619 | $N/A | $-1 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 3,319 | 1,674 |
| Debt Repayment | N/A | N/A | -1,900 | -475 | -107 |
| Common Stock Issued | 12,081 | 4,093 | 43,560 | N/A | N/A |
| Common Stock Repurchased | -3,140 | -541 | -99 | N/A | N/A |
| Other Financing Activity | 348 | -126 | -2,096 | 62 | 41 |
| Financing Cash Flow | $9,290 | $3,426 | $39,465 | $2,905 | $1,608 |
| Exchange Rate Effect | -1,043 | 472 | 184 | -20 | 0 |
| Beginning Cash Position | 16,292 | 21,826 | 2,045 | 990 | 41 |
| End Cash Position | 9,687 | 16,292 | 21,826 | 2,045 | 990 |
| Net Cash Flow | $-6,606 | $-5,534 | $19,781 | $1,055 | $950 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,531 | -8,775 | -5,248 | -1,829 | -657 |
| Capital Expenditure | -1,657 | -82 | -194 | N/A | -1 |
| Free Cash Flow | -14,188 | -8,857 | -5,442 | -1,829 | -659 |